185 related articles for article (PubMed ID: 12615714)
1. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
Hempen PM; Zhang L; Bansal RK; Iacobuzio-Donahue CA; Murphy KM; Maitra A; Vogelstein B; Whitehead RH; Markowitz SD; Willson JK; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 2003 Mar; 63(5):994-9. PubMed ID: 12615714
[TBL] [Abstract][Full Text] [Related]
2. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
3. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.
Jung B; Doctolero RT; Tajima A; Nguyen AK; Keku T; Sandler RS; Carethers JM
Gastroenterology; 2004 Mar; 126(3):654-9. PubMed ID: 14988818
[TBL] [Abstract][Full Text] [Related]
4. Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells.
Rossi MR; Ionov Y; Bakin AV; Cowell JK
Cancer Genet Cytogenet; 2005 Dec; 163(2):123-9. PubMed ID: 16337854
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
[TBL] [Abstract][Full Text] [Related]
6. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.
Patsos G; André S; Roeckel N; Gromes R; Gebert J; Kopitz J; Gabius HJ
Glycobiology; 2009 Jul; 19(7):726-34. PubMed ID: 19293232
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
[TBL] [Abstract][Full Text] [Related]
8. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
Biswas S; Trobridge P; Romero-Gallo J; Billheimer D; Myeroff LL; Willson JK; Markowitz SD; Grady WM
Genes Chromosomes Cancer; 2008 Feb; 47(2):95-106. PubMed ID: 17985359
[TBL] [Abstract][Full Text] [Related]
9. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
Park B; Jang JS; Park K
Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
[TBL] [Abstract][Full Text] [Related]
10. Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability.
Fernández-Peralta AM; Nejda N; Oliart S; Medina V; Azcoita MM; González-Aguilera JJ
Cancer Genet Cytogenet; 2005 Feb; 157(1):18-24. PubMed ID: 15676142
[TBL] [Abstract][Full Text] [Related]
11. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair.
Chung H; Young DJ; Lopez CG; Le TA; Lee JK; Ream-Robinson D; Huang SC; Carethers JM
PLoS One; 2008; 3(10):e3463. PubMed ID: 18941508
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
14. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.
Jung BH; Beck SE; Cabral J; Chau E; Cabrera BL; Fiorino A; Smith EJ; Bocanegra M; Carethers JM
Gastroenterology; 2007 Feb; 132(2):633-44. PubMed ID: 17258738
[TBL] [Abstract][Full Text] [Related]
15. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.
Myeroff LL; Parsons R; Kim SJ; Hedrick L; Cho KR; Orth K; Mathis M; Kinzler KW; Lutterbaugh J; Park K
Cancer Res; 1995 Dec; 55(23):5545-7. PubMed ID: 7585631
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.
Parsons R; Myeroff LL; Liu B; Willson JK; Markowitz SD; Kinzler KW; Vogelstein B
Cancer Res; 1995 Dec; 55(23):5548-50. PubMed ID: 7585632
[TBL] [Abstract][Full Text] [Related]
17. Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers.
Jung B; Smith EJ; Doctolero RT; Gervaz P; Alonso JC; Miyai K; Keku T; Sandler RS; Carethers JM
Int J Cancer; 2006 May; 118(10):2509-13. PubMed ID: 16380996
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
[TBL] [Abstract][Full Text] [Related]
19. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
Grady WM; Myeroff LL; Swinler SE; Rajput A; Thiagalingam S; Lutterbaugh JD; Neumann A; Brattain MG; Chang J; Kim SJ; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
Cancer Res; 1999 Jan; 59(2):320-4. PubMed ID: 9927040
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.
Lücke CD; Philpott A; Metcalfe JC; Thompson AM; Hughes-Davies L; Kemp PR; Hesketh R
Cancer Res; 2001 Jan; 61(2):482-5. PubMed ID: 11212236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
